About Intravacc
Intravacc is a company based in Bilthoven (Netherlands) founded in 2012. Intravacc offers products and services including Process Development, Analytical Method Development, and GMP Manufacturing. Intravacc operates in a competitive market with competitors including Neovacs, Fina Biosolutions, VERAXA, Yapanbio and Primrose Bio, among others.
- Headquarter Bilthoven, Netherlands
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$633 K (USD), Grant
Jan 16, 2024
-
Investors
CARB-X
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intravacc
Intravacc offers a comprehensive portfolio of products and services, including Process Development, Analytical Method Development, and GMP Manufacturing.
Develops vaccine processes from discovery to clinical trials
Creates methods for vaccine quality and analysis
Produces vaccines under regulated manufacturing standards
People of Intravacc
Unlock access to complete
Funding Insights of Intravacc
Investors in Intravacc
Intravacc has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include CARB-X and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Antibiotics, vaccines, and diagnostics against drug-resistant bacteria are developed.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Intravacc
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Intravacc
Investment portfolio details for Intravacc
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Intravacc
Detailed financials for Intravacc
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intravacc Comparisons
Peer comparison for Intravacc
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Intravacc
Intravacc operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neovacs, Fina Biosolutions, VERAXA, Yapanbio and Primrose Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccine manufacturing services are provided by Neovacs CDMO.
|
|
| Locked | Locked | Locked |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| Locked | Locked | Locked |
Antibody therapeutics for cancer treatment are developed via microfluidic screening.
|
|
| Locked | Locked | Locked |
Contract manufacturing of bio-therapeutics and vaccines is provided.
|
|
| Locked | Locked | Locked |
New molecules are discovered, developed, and manufactured in biotechnology.
|
Detailed competitors of Intravacc
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intravacc
Complete news archive for Intravacc
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intravacc
Intravacc was founded in 2012 and raised its 1st funding round 10 years after it was founded.
Intravacc is headquartered in Bilthoven, Netherlands. It is registered at Bilthoven, Utrecht, Netherlands.
Intravacc was founded in 2012 and is based in Bilthoven, Netherlands. Operations focus on the biotechnology sector, where bacterial and viral vaccines are developed using the Vero cell line, along with conjugation and adjuvants. Assay development, vaccine characterization, and pilot-scale manufacturing are offered, as well as 3R research in animal models. Platforms such as OMV technology, Vero cell, and iBoost technology are utilized.
Intravacc offers Process Development, Analytical Method Development, and GMP Manufacturing.
Intravacc has 2 investors. Key investors include CARB-X, and European Union.